Clinical Trials Sponsored by Celgene Corporation
Total 7414 results
-
CelgeneCelgene CorporationCompletedLymphoma | CancerUnited States, United Kingdom
-
Celgene CorporationCompleted
-
Celgene CorporationCompletedLow- or Intermediate-1-risk Myelodysplastic Syndrome (MDS)United States
-
Celgene CorporationTerminatedColorectal CancerAustralia, Belgium, Germany, Italy, Spain, Sweden
-
Celgene CorporationCompletedMyelodysplastic SyndromesUnited States, Denmark, Australia, Belgium, Czech Republic, France, Germany, Greece, Italy, Netherlands, Russian Federation, Spain, Sweden, Switzerland, United Kingdom
-
Celgene CorporationCompletedMultiple MyelomaIreland, Spain, Australia, Austria, United Kingdom
-
Celgene CorporationCompletedSmall Cell Lung CancerUnited States
-
Celgene CorporationWithdrawnMetastatic Breast CancerUnited States
-
Celgene CorporationCompletedNeoplasms | FatigueUnited States
-
Celgene CorporationCompletedMyelodysplastic SyndromesUnited States
-
CelgeneCelgene CorporationCompletedGlioma | Solid Tumor | Angioimmunoblastic T-cell Lymphoma | Chondrosarcoma | Intrahepatic CholangiocarcinomaUnited States, France
-
CelgeneCelgene CorporationTerminatedAdvanced Solid TumorsUnited States
-
CelgeneCelgene CorporationCompletedMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States, Australia
-
Celgene CorporationCompletedMultiple MyelomaUnited States, Spain, Australia, Canada, United Kingdom, Italy, Switzerland, Bulgaria, Poland, Ukraine, Belgium, Germany, Hungary, Ireland, Israel, Russian Federation
-
Celgene CorporationTerminated
-
Celgene CorporationCompletedRelapsed or Refractory Multiple MyelomaGermany
-
Celgene CorporationTerminatedDiffuse Large B-cell LymphomaUnited States, Canada, Australia
-
Celgene CorporationCompletedComplex Regional Pain Syndrome (RSD)United States
-
Celgene CorporationCompletedGlioblastoma | Malignant GliomasUnited States
-
CelgeneCelgene CorporationCompletedCutaneous T-cell LymphomaUnited States, France, Germany, Poland, Russian Federation, United Kingdom
-
Celgene CorporationCompletedHealthy SubjectsUnited States
-
Celgene CorporationTerminatedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Multiple Myeloma | Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Non-Hodgkin LymphomaJapan
-
Celgene CorporationCompletedHealthy VolunteersUnited States
-
Celgene CorporationWithdrawn
-
Celgene CorporationTerminatedComplex Regional Pain Syndrome, Type IUnited States
-
Celgene CorporationUnknown
-
Celgene CorporationCompleted
-
Celgene CorporationCompletedRadiculopathyUnited States
-
Celgene CorporationCompletedMultiple MyelomaUnited States
-
Celgene CorporationTerminatedMyeloid LeukemiaUnited States
-
Celgene CorporationCompletedSafety and Efficacy of CC-4047 in Subjects With Metastatic Hormone Refractory Prostate Cancer (HRPC)Prostate CancerUnited States
-
Celgene CorporationCompletedMelanoma | Neoplasm MetastasisUnited States, Canada
-
Celgene CorporationCompletedCrohn's DiseaseFrance, United States, United Kingdom, Israel
-
Celgene CorporationCompleted
-
Celgene CorporationCompletedBreast Neoplasms | Metastases, NeoplasmUnited States
-
Celgene CorporationCompletedMultiple MyelomaUnited States
-
Celgene CorporationCompletedNeoplasms | Metastases, NeoplasmUnited States
-
Celgene CorporationCompleted
-
Celgene CorporationTerminated
-
Celgene CorporationCompletedLeukemia Lymphocytic Chronic B-CellUnited States, Germany
-
Celgene CorporationCompleted
-
Celgene CorporationCompletedNewly Diagnosed Multiple MyelomaSpain, Netherlands, Austria, Australia, Italy, Russian Federation, United Kingdom, Israel, Belgium, Greece, Germany, Poland, Turkey, France, Denmark, Czech Republic, Belarus, Georgia, Ireland, Sweden, Switzerland, Ukraine
-
Celgene CorporationCompletedNon-Small Cell Lung CancerUnited States
-
Celgene CorporationCompletedMultiple MyelomaUnited States, Canada
-
Celgene CorporationCompletedBreast Neoplasms | Metastases, NeoplasmUnited States
-
CelgeneBeiGeneTerminatedCarcinoma, Non-Small-Cell LungSpain, United States, Japan, China, Canada, United Kingdom, Belgium, Singapore, Korea, Republic of, Netherlands, France, Romania, Greece, Germany, Taiwan, Finland, Italy, Poland, Hungary, Ireland, Portugal, New Zealand, Russian Federation
-
Celgene CorporationPfizerTerminatedDiarrhea | Colorectal NeoplasmsUnited States
-
OncotherapeuticsCelgene CorporationCompletedMultiple MyelomaUnited States
-
OncotherapeuticsCelgene CorporationTerminatedMultiple MyelomaUnited States
-
OncotherapeuticsCelgene CorporationUnknownMultiple MyelomaUnited States